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Abstract
Purpose
Quantitative computed tomography (QCT) provides important prognostic information of cor-
onary atherosclerosis. We investigated intraobserver and interobserver QCT reproducibility
in asymptomatic individuals, patients with acute chest pain without acute coronary syn-
drome (ACS), and patients with acute chest pain and ACS.
Methods
Fifty patients from each cohort, scanned between 01/02/2010-14/11/2013 and matched
according to age and gender, were retrospectively assessed for inclusion. Patients with no
coronary artery disease, previous coronary artery bypass graft surgery, and poor image
quality were excluded. Coronary atherosclerosis was measured semi-automatically by 2
readers. Reproducibility of minimal lumen area (MLA), minimal lumen diameter (MLD), area
stenosis, diameter stenosis, vessel remodeling, plaque eccentricity, plaque burden, and pla-
que volumes was assessed using concordance correlation coefficient (CCC), Bland-Altman,
coefficient of variation, and Cohen’s kappa.
Results
A total of 84 patients (63 matched) were included. Intraobserver and interobserver reproduc-
ibility estimates were acceptable for MLA (CCC = 0.94 and CCC = 0.91, respectively), MLD
(CCC = 0.92 and CCC = 0.86, respectively), plaque burden (CCC = 0.86 and CCC = 0.80,
respectively), and plaque volume (CCC = 0.97 and CCC = 0.95, respectively). QCT
detected area and diameter stenosis�50%, positive remodeling, and eccentric plaque with
moderate-good intraobserver and interobserver reproducibility (kappa: 0.64–0.66, 0.69–
0.76, 0.46–0.48, and 0.41–0.62, respectively). Reproducibility of plaque composition
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decreased with decreasing plaque density (intraobserver and interobserver CCC for dense
calcium (>0.99; 0.98), fibrotic (0.96; 0.93), fibro-fatty (0.95; 0.91), and necrotic core tissue
(0.89; 0.84). Reproducibility generally decreased with worsening clinical risk profile.
Conclusions
Semi-automated QCT of coronary plaque morphology is reproducible, albeit with some
decline in reproducibility with worsening patient risk profile.
Introduction
Multidetector computed tomography (MDCT) is a guideline recommended non-invasive
imaging modality for the assessment of obstructive coronary artery disease (CAD)[1]. Recent
advancements in software technology now allow for semi-automated quantitative assessment
of coronary atherosclerosis, thereby providing a detailed description of coronary plaque mor-
phology with the potential for improved reproducibility and accuracy compared to traditional
qualitative MDCT assessments[2].
Good reproducibility of quantitative computed tomography (QCT) is important for diag-
nostic purposes and for risk-stratification purposes in various patient populations[3–5]. Coro-
nary plaque morphology has, however, been shown to differ in different patient populations,
with the majority of research conducted in patients with stable angina and in patients with
acute coronary syndrome (ACS)[6,7]. It can be hypothesized that these differences may affect
QCT reproducibility assessments as correct identification of mild levels of coronary disease,
especially non-calcified plaque[2], as well as correct discernment of lumen and vessel contours
in severe levels of coronary disease, especially combined with even slight motion, noise, or
blooming artifacts, can be difficult. Studies investigating intraobserver and interobserver
reproducibility using semi-automated QCT are, however, few and reproducibility has only
been investigated in relatively small numbers of highly selected patients with low-intermediate
plaque burdens[8–11].
In this study, we investigated intraobserver and interobserver QCT reproducibility in
asymptomatic individuals, patients with acute chest pain without ACS, and patients with acute
chest pain and ACS.
Material and methods
Study population
All participants included in this study underwent MDCT at The Department of Radiology,
Rigshospitalet, Copenhagen, Denmark. All patients gave written informed consent to have a
MDCT performed for research purposes and the local ethics committee approved individual
study protocols. This study was approved by The Danish Data Protection Agency and all proce-
dures performed in studies involving human participants were in accordance with the ethical
standards of the institutional and/or national research committee and with the 1964 Helsinki
declaration and its later amendments or comparable ethical standards.
Asymptomatic individuals from the general population were recruited from The Copenha-
gen General Population Study, CGPS[12]. Patients presenting with acute chest pain but without
signs of ACS were recruited from Cardiac CT in the Treatment of Acute Chest Pain, CATCH
(clinical trial number NCT01534000)[13]. Patients fulfilling criteria for either unstable angina
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pectoris or non-ST elevation myocardial infarction were recruited from Very Early versus
Deferred Invasive Evaluation using Computerized Tomography in Patients with Acute Coronary
Syndromes, VERDICT (clinical trial number NCT02061891).
Fifty patients were randomly selected from the VERDICT cohort and subsequently matched
according to age and gender with participants from the CGPS and CATCH trial, as described
in a previous study where all 150 participants have been reported[2]. This prior study dealt
with the reproducibility of qualitatively assessed coronary atherosclerosis[2]. Matching was
prioritised in this study as increasing burden of CAD and increasing calcification with age and
gender are well known factors that could influence reproducibility estimates if not accounted
for. Of these 150 participants scanned between 01/02/2010-14/11/2013, participants without
coronary artery disease (as assessed by 2 readers) and with coronary artery bypass grafts
(CABG) did not undergo QCT. Furthermore, MDCT datasets with image quality deemed
unsuitable for semi-automated plaque quantification due to severe motion, noise, calcification,
pacemaker artifacts, field of view problems, and poor contrast timing, were excluded as previ-
ously described[14].
MDCT image data, medical history and cardiovascular risk profile were acquired from the
respective study databases. In this study, participants were divided into three subpopulations
based on clinical presentation: Asymptomatic (CGPS participants), Acute chest pain–(minus)
ACS (CATCH participants), and Acute chest pain + ACS (VERDICT participants).
MDCT scan protocol
All participants with a heart rate>60 beats per minute (bpm) and no contraindications to beta
blockade were pretreated with oral beta blockers according to a standardised protocol. If nec-
essary, intravenous beta blocker (CATCH and VERDICT participants) was given just before
scanning. Patients received 0.8 mg nitroglycerin prior to scanning if no contraindications
were present. All participants were in sinus rhythm during scanning.
Image acquisition was performed using a 320-slice MDCT (Aquilion one, Vision Edition,
Canon, Tokyo, Japan). Overall scan protocol: 320 x 0.5 mm detector collimation, a median
(interquartile range (IQR)) tube voltage of 120 (100, 120) kV (body mass index (BMI) depen-
dent), a median (IQR) tube current of 450 (410, 500) mA, and a gantry rotation time of median
(IQR) of 0.35 (0.35, 0.35) s (heart rate dependent). Intravenous contrast media (Visipaque, GE
Healthcare, Chalfont St. Giles, United Kingdom (CGPS and VERDICT) or Omnipaque, GE
Healthcare, Chalfont St. Giles, United Kingdom (CATCH)) was infused with a flow rate of
5.0–6.0 ml/s (weight dependent) with a biphasic injection protocol followed by a saline chaser.
The automatic bolus triggering technique was used for initiating image acquisition. Recon-
structions at best phase of the R-R interval using an automatic raw data motion analysis tool
(PhaseXact, Toshiba) were performed. Images were reconstructed with 0.5 mm slice thickness
and increments of 0.25 mm. The conversion factor 0.014 mSv/(mGyxcm) was used to calculate
the effective radiation dose.
Quantitative plaque analysis
QCT of coronary atherosclerotic plaque per segment was performed in a semi-automated
manner using dedicated software (QAngio CT Research Edition version 2.02, Medis Medical
Imaging Systems, Leiden, The Netherlands) by 2 readers with 1 year and 3 years of reading
experience, respectively. Coronary tree extraction with the generation of multiplanar reformat-
ted (MPR) volumes using an automatic tree extraction algorithm[15] and coronary vessel seg-
mentation (in accordance with Society of Cardiovascular Computed Tomography (SCCT)
guidelines[1]) was performed by the primary reader. If no vessel branches were present to
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indicate a given segment border, vessel lengths were divided up into thirds to provide proxi-
mal, mid, and distal segments. The extracted coronary tree with segment borders (but no ves-
sel wall or lumen contours) was then loaded and assessed by reader 1 twice with a 3 month
interval (measurement 1 and measurement 2) for the assessment of intraobserver reproduc-
ibility and by reader 2 (blinded) for the assessment of interobserver reproducibility. Calcula-
tion of interobserver reproducibility was done using measurement 2 by reader 1 and the
measurements by reader 2.
Each reader performed automatic lumen and outer vessel wall contour registration[16,17]
followed by manual editing in longitudinal and transverse vessel views of both the lumen and
outer vessel wall contours when needed. As determined by each reader, coronary segments of
included individuals with motion, severe image noise, severe calcification, <1.5 mm in vessel
diameter, occlusions with limited retrograde contrast filling, and segments with stents travers-
ing the entire length of a given segment were not assessed. Furthermore, only segments with
coronary atherosclerotic plaque (of any degree) underwent QCT assessment: If a reader deter-
mined that there was coronary plaque in a given segment, the reader determined the proximal
and distal borders of the lesion visually and QCT parameters were automatically calculated for
the lesion, see Fig 1. An automatic reference method where a regression analysis is used on the
Fig 1. Example of quantitative analysis of a proximal left anterior descending artery segment. A. Longitudinal straightened multiplanar reconstruction where S and
E are the start and end of the segment, respectively; P and D are the proximal and distal borders of the lesion, respectively; O is the point of maximal obstruction. B.
Transverse vessel view at the point of maximal obstruction.
https://doi.org/10.1371/journal.pone.0207980.g001
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whole lesion to obtain a linear reference was used in the calculation of remodeling index (RI),
area stenosis and diameter stenosis.
Plaque composition was assessed using Hounsfield unit (HU) cut-off values adapted to
lumen attenuation[18]. This is based on the principle that lumen intensities influence plaque
intensity and decrease along the length of a vessel, are lower in vessel segments with severe ste-
noses, and are higher in vessel segments with calcified plaque due to blooming artifacts[17–
19]. Definitions of QCT derived parameters are given in Table 1.
Data are reported on both a lesion and patient basis (supplementary material) for the total
population and for the subset of age and gender matched individuals.
Statistics
Continuous normally distributed data are presented as mean (standard deviation, SD) and
continuous non-normally distributed data as median (IQR). Categorical data are presented as
absolute numbers (percentages). One-way analysis of variance and the Kruskall-Wallis test
were used to assess differences in normally distributed data and non-normally distributed
data, respectively. The χ2-test was used to test for differences in categorical data. Intraobserver
and interobserver reproducibility estimates were analysed using Lin’s concordance correlation
coefficient (CCC with 95% confidence intervals (CI))[20]. Furthermore, Bland Altman analy-
ses, with mean bias (95% CI) and 95% limits of agreement, were conducted[21]. Normality of
mean differences of all parameters was tested. Furthermore, the coefficient of variation (CV), a
measure of variability relative to the mean, was calculated as (SD of the mean difference/total
average of the mean values for each pair)x100. Intraobserver and interobserver reproducibility
was calculated in all participants and across subpopulations. Reproducibility for categorical
variables was assessed using Cohen’s Kappa (κ) and were interpreted as: absence of agreement
�0; poor agreement 0.00–0.20; fair agreement 0.21–0.40; moderate agreement 0.41–0.60;
good agreement 0.61–0.80; and excellent agreement >0.80[22]. All statistical analyses were
Table 1. Definitions of quantitative computed tomography (QCT) derived parameters.
QCT parameter Definition
Lumen and vessel geometry Minimal lumen area
(MLA), mm2
The minimal lumen area at the point of maximal obstruction
Area stenosis, % = 1-(MLA/reference lumen area) x 100
Minimal lumen diameter
(MLD), mm
The minimal lumen diameter at the point of maximal obstruction
Diameter stenosis, % = 1-(MLD/reference lumen diameter) x 100
Remodeling index = vessel area at the point of maximal obstruction/reference vessel area
Coronary plaque
parameters
Distribution and
burden
Eccentricity index At the point of maximal obstruction:
= (maximum plaque thickness-minimum plaque thickness)/maximum plaque thickness
Plaque burden, % Between the proximal and distal ends of the coronary lesion:
= (vessel volume-lumen volume)/vessel volume x 100
Volume and
composition
Plaque volume, mm3 Between the proximal and distal ends of the coronary lesion:
= vessel volume-lumen volume
Fibrotic volume, mm3 The volume based on all the pixel area measurements of the fibrous plaque category
between the proximal and distal ends of the coronary lesion
Fibro-fatty volume, mm3 The volume based on all the pixel area measurements of the fibro-fatty plaque category
between the proximal and distal ends of the coronary lesion
Necrotic core volume,
mm3
The volume based on all the pixel area measurements of the necrotic core plaque category
between the proximal and distal ends of the coronary lesion
Dense calcium volume,
mm3
The volume based on all the pixel area measurements of the dense calcium plaque category
between the proximal and distal ends of the coronary lesion
https://doi.org/10.1371/journal.pone.0207980.t001
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performed using SPSS version 22, SPSS Inc., Chicago, IL, USA). Graphical illustrations were
constructed using GraphPad Prism version 6.01 for Windows, GraphPad Software, San Diego
California USA. P-values <0.05 were considered statistically significant.
Results
Patient population
Out of 150 selected participants, a total of 84 participants were included in this study, see Fig 2.
Of these 84 included participants, 63 were matched 1:1 according to age and gender. Baseline
characteristics for all 84 participants and for the three matched subpopulations are shown in
Table 2. Of the 1428 segments available for analysis, segments with no atherosclerosis, motion,
noise, severe calcification, vessel diameter<1.5 mm, limited retrograde contrast filling after
occlusion, and stents were excluded and 343 and 335 paired measurements were obtained for
intraobserver and interobserver assessment, respectively.
Geometrical vessel and lumen parameters
Reproducibility estimates for minimal lumen area (MLA), area stenosis, minimal lumen diam-
eter (MLD), and diameter stenosis are shown in Table 3, and Figs 3 and 4. MLA and MLD had
good intraobserver and interobserver reproducibility with acceptable CCC and CV values,
mean biases close to zero, and narrow limits of agreement. Reproducibility for area stenosis
and diameter stenosis was weaker than their reference independent counterparts and limits of
agreement for area stenosis and diameter stenosis ranged between -23.5 to 23.5% and -17.1 to
17.3% for intraobserver reproducibility and between -29.9 to 29.3% and -21.8 to 21.4% for
interobserver reproducibility, respectively.
Using a binary approach, reproducibility of area and diameter stenosis (using a cut-off of
50% to identify lesions with and without significant stenosis) was found to be good for both
Fig 2. Flow chart of patient inclusion. ACS acute coronary syndrome; CABG coronary artery bypass graft.
https://doi.org/10.1371/journal.pone.0207980.g002
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intraobserver reproducibility (area stenosis κ (95% CI): 0.66 (0.55; 0.77), p<0.001; diameter steno-
sis κ (95% CI): 0.76 (0.65; 0.87), p<0.001) and interobserver reproducibility (area stenosis κ (95%
CI): 0.64 (0.53; 0.74), p<0.001; diameter stenosis κ (95% CI): 0.69 (0.58; 0.80), p<0.001).
Reproducibility estimates of the RI on a continuous scale were weak (intraobserver and
intraobserver CCC of 0.53 and 0.57, respectively), Table 3. Using a binary approach, reproduc-
ibility of positive remodeling (using the standard cut-off of�1.10 to identify positively remod-
elled lesions) was moderate for both intraobserver reproducibility (κ (95% CI): 0.48 (0.36;
0.60), p<0.001) and interobserver reproducibility (κ (95% CI): 0.46 (0.34; 0.58), p<0.001).
Plaque eccentricity and plaque burden
Reproducibility estimates of the eccentricity index (EI) on a continuous scale were weak
(intraobserver and interobserver CCC of 0.64 and 0.58, respectively), Table 3. Using a binary
approach, reproducibility of eccentric plaque (defined as EI�0.67, corresponding to maximal
plaque thickness thrice that of minimal plaque thickness at the site of maximal obstruction)
was good for intraobserver reproducibility (κ (95% CI): 0.62 (0.52; 0.73), p<0.001) and moder-
ate for interobserver reproducibility (κ (95% CI): 0.41 (0.30; 0.52), p<0.001).
Reproducibility estimates for plaque burden showed acceptable intraobserver and interob-
server reproducibility with CCCs ranging from 0.80–0.86, mean biases close to zero, relatively
narrow limits of agreement, and good CVs, Table 3, Figs 3 and 4.
Plaque volume and plaque composition
Reproducibility estimates of plaque volumes on a lesion basis and patient basis for both
intraobserver and interobserver reproducibility were good, Table 3, S1 Table, Figs 3 and 4.
Table 2. Baseline characteristics.
All Asymptomatic Acute chest pain—ACS Acute chest pain
+ ACS
p-value
n 84 21 21 21
Age, mean (SD) 66.2 (8.4) 66.7 (8.2) 66.2 (8.4) 65.8 (8.0) -
Male, n (%) 51 (61) 14 (67) 14 (67) 14 (67) -
Family history of CAD, n (%) 24 (35) 4 (27) 2 (10) 10 (63) <0.01
Hypertension, n (%) 48 (57) 15 (71) 12 (57) 12 (57) 0.55
Hypercholesterolemia, n (%) 39 (48) 9 (43) 13 (62) 9 (47) 0.44
Diabetes, n (%) 9 (11) 1 (5) 3 (14) 4 (19) 0.37
Current smoking, n (%) 25 (30) 3 (14) 10 (48) 3 (16) <0.05
Known CAD, n (%) 16 (19) 2 (10) 8 (38) 4 (19) 0.08
Prior AMI, n (%) 14 (17) 2 (10) 6 (29) 4 (19) 0.29
Height, mean (SD) 173.2 (9.4) 173.2 (9.0) 173.0 (9.3) 175.9 (10.1) 0.58
Weight, mean (SD) 79.9 (16.9) 78.0 (12.4) 83.6 (18.1) 81.9 (18.2) 0.53
BMI, mean (SD) 26.4 (4.0) 25.9 (3.3) 27.7 (4.6) 26.2 (3.7) 0.29
<50% stenosis, n (%) 49 (58) 18 (86) 13 (62) 6 (29) <0.01
1 vessel disease, n (%) 21 (25) 3 (14) 4 (19) 9 (43)
2 vessel disease, n (%) 12 (14) 0 (0) 3 (14) 6 (29)
3 vessel disease, n (%) 2 (2) 0 (0) 1 (5) 0 (0)
Heart rate, mean (SD) 58.8 (7.3) 58.7 (6.6) 60.8 (10.2) 59.3 (5.0) 0.67
Contrast (ml), median (IQR) 80 (70, 80) 80 (80, 80) 70 (70, 80) 90 (70, 90) <0.05
Effective radiation dose (mSv), median (IQR) 2.8 (1.5, 3.9) 1.5 (1.3, 1.6) 3.6 (2.9, 6.1) 3.3 (2.8, 3.9) <0.001
CAD coronary artery disease; AMI acute myocardial infarction; BMI body mass index; SD standard deviation; IQR interquartile range
https://doi.org/10.1371/journal.pone.0207980.t002
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With regards to plaque composition for both intraobserver and interobserver reproducibility,
decreasing CCCs and increasing CVs were seen with decreasing coronary plaque density.
Reproducibility estimates across subpopulations
Reproducibility estimates of coronary plaque parameters across subpopulations on a lesion
basis and patient basis are given in Table 4 and S2 Table, respectively.
Geometrical vessel and lumen parameters: Intraobserver and interobserver reproducibility
of MLA and MLD, though acceptable in all subpopulations, decreased with worsening clinical
risk profile, as is expressed by widening limits of agreement and increasing CV. Intraobserver
reproducibility of area and diameter stenosis was highest in the “Chest pain + ACS” subpopu-
lation. Interobserver reproducibility of area and diameter stenosis, however, did not vary nota-
bly across subpopulations. Limits of agreement for RI increased (along with CV) with
worsening clinical risk profile.
Plaque eccentricity and plaque burden: Limits of agreement for EI increased (along with
CV) with worsening clinical risk profile. Intraobserver and interobserver reproducibility esti-
mates for plaque burden were acceptable in all subpopulations but limits of agreement and CV
increased with worsening clinical risk profile.
Plaque volume and plaque composition: Reproducibility of total plaque volume was accept-
able in all subpopulations and, for interobserver reproducibility, was highest in the “Chest
Table 3. Intraobserver and interobserver reproducibility estimates on a lesion basis.
Intraobserver reproducibility
n = 343 lesions
Interobserver reproducibility
n = 335 lesions
CCC 95% CI Mean bias
±1.96SD
95% CI of mean
bias
CV (%) CCC 95% CI Mean bias
±1.96SD
95% CI of mean
bias
CV (%)
Min. lumen area, mm2 0.94 0.922–
0.948
-0.2±2.4 -0.3; 0.0 24 0.91 0.884–
0.922
0.2±2.8 0.1; 0.4 29
Area stenosis, % 0.84 0.806–
0.868
0.0±23.5 -1.3; 1.3 29 0.77 0.718–
0.807
-0.3±29.6 -1.9; 1.3 36
Min. lumen diameter,
mm
0.92 0.906–
0.937
0.0±0.6 -0.1; 0.0 14 0.86 0.824–
0.881
0.1±0.8 0.1; 0.2 19
Diameter stenosis, % 0.85 0.814–
0.874
0.1±17.2 -1.0; 0.8 34 0.77 0.725–
0.812
-0.2±21.6 -1.4; 1.0 43
Remodeling index 0.57 0.489–
0.634
0.0±0.3 0.0; 0.0 17 0.53 0.447–
0.602
0.0±0.3 0.0; 0.0 17
Eccentricity index 0.64 0.576–
0.700
0.0±0.2 0.0; 0.0 15 0.58 0.504–
0.646
0.0±0.3 0.0; 0.0 17
Plaque burden, % 0.86 0.859–
0.905
0.6±10.0 0.0; 1.1 9 0.80 0.761–
0.835
-3.0±12.0 -3.7; -2.4 11
Plaque volume, mm3 0.97 0.967–
0.978
3.7±48.3 1.1; 6.4 20 0.95 0.940–
0.960
0.0±64.3 -3.5; 3.5 27
Dense calcium, mm3 >0.99 0.995–
0.997
0.2±6.5 -0.1; 0.6 13 0.98 0.973–
0.981
-3.3±13.0 -4.0; -2.6 25
Fibrotic, mm3 0.96 0.953–
0.969
2.8±28.8 1.3; 4.4 23 0.93 0.919–
0.946
0.9±37.9 -1.2; 2.9 31
Fibro-fatty, mm3 0.95 0.935–
0.957
0.6±13.9 -0.2; 1.3 30 0.91 0.887–
0.924
1.5±17.6 0.6; 2.5 39
Necrotic core, mm3 0.89 0.868–
0.912
0.1±8.5 -0.4; 0.6 50 0.84 0.804–
0.866
0.8±9.0 0.3; 1.3 57
CCC concordance correlation coefficient; SD standard deviation; CV coefficient of variation; CI confidence interval
https://doi.org/10.1371/journal.pone.0207980.t003
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pain–ACS” subpopulation. On a lesion basis, a pattern of worsening reproducibility for plaque
composition with decreasing plaque density was seen.
Discussion
This study, to our knowledge, is the largest comprehensive examination of reproducibility of
semi-automated plaque quantification in and across populations with different clinical presen-
tations. The main findings of this study are: Firstly, reproducibility of MLA, MLD, plaque bur-
den, and plaque volumes was acceptable. Reproducibility was poorer for area stenosis,
diameter stenosis, RI, and EI assessed on a continuous scale but acceptable using a categorical
approach. Secondly, reproducibility varied for compositional measures where coronary plaque
with higher densities had better reproducibility than coronary plaque with lower densities.
Thirdly, reproducibility of the investigated parameters generally decreased with worsening
clinical risk profile. Overall, this study showed that semi-automated plaque quantification pro-
vided reproducible assessments of clinically relevant coronary plaque geometry, plaque distri-
bution, plaque burden, and plaque volumes, especially high density plaque volumes.
Our findings on the reproducibility of total plaque volume and low density plaque are com-
parable with a study by Øvrehus et al[8] who demonstrated an intraobserver and interobserver
CV of 8% and 12% respectively for total plaque volume (compared to CV 11% and 17% respec-
tively in the present study). Furthermore, Øvrehus et al documented a CV of 46% (intraobser-
ver reproducibility) and 43% (interobserver reproducibility) for non-calcified plaque volume
which is comparable with the findings of reproducibility for fibro-fatty and necrotic core tissue
that ranged from 30% to 57% in the present study.
With regards to the poorer reproducibility found in lower plaque densities compared to
higher plaque densities, other studies have found similar results[5,9]. Our findings may be due
manual editing of the automatic vessel and lumen contours which may have contributed to
higher intraobserver and interobserver variability, as has also been reported by Laqmani et al
[11] and Blackmon et al[23]. Additionally, as discussed by Papadopoulou et al, decreased
reproducibility of non-calcified plaque could be explained by incorrect incorporation of the
lumen or pericoronary fat in the plaque area[9].
Across subpopulations, reproducibility of QCT parameters was seen to generally decrease
with worsening clinical risk profile. This is an important observation as it relates to the clinical
feasibility of QCT in different patient populations. This finding is most likely due to differ-
ences in plaque composition and disease burden between the investigated subpopulations. It
has been shown that coronary atherosclerotic plaque volume and composition are strongly
associated to clinical presentation and several studies have previously reported increased total
non-calcified plaque volume and low attenuation plaque volume in patients with ACS com-
pared to patients with stabile angina and asymptomatic individuals[6,7,24].
As discussed, fibro-fatty and necrotic core tissue showed poorer reproducibility compared
to fibrous and dense calcium tissue. The greater volumes of lower density plaque in popula-
tions with greater likelihood of CAD would, therefore, not only result in poor reproducibility
of non-calcified plaque but also of geometrical, distributional, burden and volume related
parameters. This is exemplified by the findings of Kang et al who reported a decreased sensitiv-
ity to detect diameter stenosis >50% in non-calcified plaque due to underestimation when
using automated techniques compared with visual assessments[25]. Furthermore, increased
Fig 3. Intraobserver reproducibility (lesion basis) for minimal lumen area, minimal lumen diameter, plaque burden, and plaque volume. A-D
show Bland Altman plots for minimal lumen area, minimal lumen diameter, plaque burden, and plaque volume, respectively; a-d show correlations
for minimal lumen area, minimal lumen diameter, plaque burden, and plaque volume, respectively.
https://doi.org/10.1371/journal.pone.0207980.g003
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disease burden potentially requires greater manual correction when using semi-automated
quantification techniques, thereby introducing greater variability into QCT measurements.
This is important with regards to potential implementation of QCT in a clinical setting and
emphasizes the importance of accurate automatic identification of especially non-calcified
plaque.
At present QCT requires excellent image quality for accurate plaque measurements and, in
addition for the need to further automate quantitative coronary plaque assessments, there is
Fig 4. Interobserver reproducibility (lesion basis) for minimal lumen area, minimal lumen diameter, plaque burden, and plaque volume. A-D
show Bland Altman plots for minimal lumen area, minimal lumen diameter, plaque burden, and plaque volume, respectively; a-d show correlations
for minimal lumen area, minimal lumen diameter, plaque burden, and plaque volume, respectively.
https://doi.org/10.1371/journal.pone.0207980.g004
Table 4. Intraobserver and interobserver reproducibility in each cohort on a lesion basis in age and gender matched patients.
Asymptomatic
(intra n = 65, inter n = 64)
Acute chest pain–ACS
(intra n = 106, inter n = 104)
Acute chest pain + ACS
(intra n = 99, inter n = 98)
Mean diff
±1.96SD
95% CI of mean
diff
CV
(%)
Mean diff
±1.96SD
95% CI of mean
diff
CV
(%)
Mean diff
±1.96SD
95% CI of mean
diff
CV
(%)
Intraobserver
reproducibility
Minimal lumen area,
mm2
-0.1±2.7 -0.4; 0.3 21 -0.3±2.0 -0.5; -0.1 24 -0.1±2.5 -0.3; 0.2 27
Area stenosis, % 0.2±22.0 -2.6; 3.0 29 0.3±26.7 -2.3; 2.9 32 0.3±18.2 -1.5; 2.2 21
Minimal lumen diameter,
mm
0.0±0.5 -0.1; 0.0 11 -0.1±0.5 -0.1; 0.0 14 0.0±0.6 -0.1; 0.0 15
Diameter stenosis, % 0.1±13.7 -1.6; 1.9 31 0.3±20.4 -1.8; 2.3 39 0.2±12.1 -1.1; 1.4 23
Remodeling index 0.0±0.2 0.0; 0.0 11 0.0±0.3 -0.1; 0.0 18 0.0±0.3 0.0; 0.0 19
Eccentricity index 0.0±0.2 0.0; 0.0 10 0.0±0.2 0.0; 0.0 16 0.0±0.3 0.0; 0.0 16
Plaque burden, % -0.3±7.0 -1.1; 0.6 7 1.3±8.9 0.4; 2.2 8 0.4±10.9 -0.7; 1.5 10
Plaque volume, mm3 4.0±52.3 -2.6; 10.6 23 -0.3±47.5 -4.9; 4.4 20 5.5±45.6 0.9; 10.2 20
Dense calcium, mm3 0.3±6.3 -0.5; 1.1 13 0.2±6.8 -0.5; 0.8 14 -0.1±6.1 -0.7; 0.5 13
Fibrotic, mm3 3.6±28.6 0.0–7.2 24 0.8±29.0 -2.1; 3.6 23 3.4±28.4 0.6; 6.3 23
Fibro-fatty, mm3 0.4±14.8 -1.5; 2.3 36 -0.5±14.0 -1.9; 0.8 28 1.4±14.3 -0.1; 2.8 31
Necrotic core, mm3 -0.3±12.1 -1.8; 1.2 66 -0.6±6.2 -1.2; 0.0 36 0.8±6.4 0.2; 1.5 42
Interobserver
reproducibility
Minimal lumen area,
mm2
0.4±2.7 0.1; 0.8 22 0.1±2.7 -0.2; 0.3 31 0.3±3.3 -0.1; 0.6 37
Area stenosis, % 2.1±30.6 -1.8; 6.0 41 -1.5±29.4 -4.4; 1.4 35 -0.5±32.3 -3.8; 2.8 37
Minimal lumen diameter,
mm
0.1±0.6 0.0, 0.2 12 0.1±0.8 0.0; 0.2 21 0.1±0.9 0.0; 0.2 24
Diameter stenosis, % 1.4±18.7 -1.0; 3.8 43 -0.8±22.3 -3.1; 1.4 44 -0.6±24.7 -3.2; 1.9 46
Remodeling index 0.0±0.3 -0.1; 0.0 14 0.0±0.3 -0.1; 0.0 18 0.0±0.3 -0.1; 0.0 18
Eccentricity index 0.0±0.2 0.0; 0.0 15 0.0±0.3 -0.1; 0.0 16 0.0±0.3 0.0; 0.0 19
Plaque burden, % -3.7±10.0 -4.9; -2.4 10 -2.5±11.4 -3.6; -1.4 11 -3.8±13.8 -5.2; -2.4 12
Plaque volume, mm3 -9.7±66.2 -18.2; -1.3 27 5.6±53.4 0.3; 10.9 23 -2.7±75.2 -10.4; 5.0 31
Dense calcium, mm3 -4.1±12.0 -5.7; -2.6 22 -2.9±12.8 -4.2; -1.6 24 -4.4±14.1 -5.9; -3.0 27
Fibrotic, mm3 -6.9±41.8 -12.3; -1.6 32 5.3±29.1 2.4;8.2 25 -0.2±43.8 -4.7; 4.3 34
Fibro-fatty, mm3 0.3±15.4 -1.6; 2.3 37 2.2±15.9 0.6; 3.8 35 1.4±21.8 -0.9; 3.6 46
Necrotic core, mm3 1.0±9.8 -0.3; 2.2 54 0.9±9.4 0.0; 1.9 61 0.5±8.5 -0.4; 1.4 56
ACS acute coronary syndrome; SD standard deviation; CV coefficient of variation; CI confidence interval
https://doi.org/10.1371/journal.pone.0207980.t004
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also a need for improvements in software technology with regards to the assessment of cur-
rently unevaluable coronary segments due to motion, noise, severe calcification, small vessel
diameter, stents, etc. Further developments in novel iterative reconstruction algorithms as well
as new scanners with higher resolution and rotation speeds, and the use of kV switching and
iodine mapping may all improve image quality and increase the feasibility of the automated
plaque assessments[26].
Perspectives
A cornerstone in the assessment of the clinical applicability of QCT is the determination of its
reproducibility. This is of particular importance as various studies have found QCT assess-
ments to be of prognostic value[3–5,27]. Furthermore, there is an increased focus on the global
assessment of coronary atherosclerotic disease–which can be achieved using QCT—for the
identification of the vulnerable patient instead of traditional assessments focusing on the iden-
tification potentially vulnerable lesions[28,29]. The findings of this study will, therefore, aid in
the further implementation of semi-automated quantitative plaque parameters for risk stratifi-
cation, especially with regards to global measures of atherosclerotic disease as our findings on
patient based coronary plaque volumes were especially good. Limitations regarding plaque
composition of fibro-fatty and necrotic core tissue, however, persist. Furthermore, current
appropriateness criteria do not recommend contrast-enhanced MDCT in asymptomatic indi-
viduals, primarily due to possible adverse effects of x-ray radiation. Our findings regarding the
good QCT reproducibility in asymptomatic individuals compared to patients with acute chest
pain, however, demonstrate the potential applicability of QCT in asymptomatic individuals,
especially since technological advancements of low-dose MDCT now allow for the attainment
of a contrast-enhanced MDCT <1 mSv[8].
Study limitations
Firstly, potential differences in MDCT scan quality between subpopulations cannot be ruled
out as the scan protocol for each of the subpopulations varied slightly (due to ethical consider-
ations concerning radiation dose). Systematic differences in image quality between subpopula-
tions would result in differences in reproducibility. Heart rate and BMI was, however, not
statistically significantly different between the subpopulations and MDCTs with the lowest
radiation doses were of participants in the “Asymptomatic” subpopulation–the subpopulation
which often had the best reproducibility estimates.
Secondly, lesions in coronary segments affected by motion, noise, severe calcification, small
vessel diameter, limited retrograde contrast filling due to occlusion, and stents were not
assessed. Improvements in software technology may, in the future, allow for the assessment of
such lesions.
Thirdly, as this is a single centre study, generalisability of our findings to other centres, due
to possible variations in data acquisition, reading, and software may be reduced.
Conclusions
This study showed that semi-automated plaque quantification provided reproducible assess-
ments of minimal lumen area, minimal lumen diameter, plaque burden, and plaque volume
and acceptably detected area and diameter stenoses�50%, positive remodeling, and eccentric
plaque. With regards to plaque composition, reproducibility was best for high density plaque
volumes. Lastly, across populations with different clinical presentations, reproducibility gener-
ally decreased with worsening clinical risk profile.
Reproducibility of quantitative coronary computed tomography angiography
PLOS ONE | https://doi.org/10.1371/journal.pone.0207980 December 14, 2018 13 / 16
Supporting information
S1 Table. Intraobserver and interobserver reproducibility estimates on a patient basis.
CCC concordance correlation coefficient; SD standard deviation; CV coefficient of variation;
CI confidence interval.
(DOCX)
S2 Table. Intraobserver and interobserver reproducibility between cohorts on a patient
basis in aged and gender matched patients. ACS acute coronary syndrome; SD standard
deviation; CV coefficient of variation; CI confidence interval.
(DOCX)
Author Contributions
Conceptualization: Martina C. de Knegt, Morten Haugen, Jesper J. Linde, Jørgen Tobias
Ku¨hl, Børge G. Nordestgaard, Lars V. Køber, Jens D. Hove, Klaus F. Kofoed.
Data curation: Martina C. de Knegt, Morten Haugen, Jesper J. Linde, Jørgen Tobias Ku¨hl,
Børge G. Nordestgaard, Lars V. Køber, Jens D. Hove, Klaus F. Kofoed.
Formal analysis: Martina C. de Knegt, Morten Haugen, Jesper J. Linde, Jørgen Tobias Ku¨hl,
Børge G. Nordestgaard, Lars V. Køber, Jens D. Hove, Klaus F. Kofoed.
Funding acquisition: Lars V. Køber, Klaus F. Kofoed.
Investigation: Martina C. de Knegt.
Methodology: Martina C. de Knegt, Jesper J. Linde, Jørgen Tobias Ku¨hl, Jens D. Hove, Klaus
F. Kofoed.
Project administration: Klaus F. Kofoed.
Resources: Jens D. Hove, Klaus F. Kofoed.
Software: Klaus F. Kofoed.
Supervision: Jesper J. Linde, Jørgen Tobias Ku¨hl, Børge G. Nordestgaard, Lars V. Køber, Jens
D. Hove, Klaus F. Kofoed.
Validation: Morten Haugen.
Writing – original draft: Martina C. de Knegt.
Writing – review & editing: Morten Haugen, Jesper J. Linde, Jørgen Tobias Ku¨hl, Børge G.
Nordestgaard, Lars V. Køber, Jens D. Hove, Klaus F. Kofoed.
References
1. Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GJ, et al. SCCT guidelines for the inter-
pretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Com-
puted Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2014; 8: 342–358. https://
doi.org/10.1016/j.jcct.2014.07.003 PMID: 25301040
2. de Knegt MC, Linde JJ, Fuchs A, Nordestgaard BG, Køber LV, Hove JD, et al. Reproducibility of coro-
nary atherosclerotic plaque characteristics in populations with low, intermediate, and high prevalence of
coronary artery disease by multidetector computer tomography: a guide to reliable visual coronary pla-
que assessments. Int J Cardiovasc Imaging. 2016; 32: 1555–1566. https://doi.org/10.1007/s10554-
016-0932-y PMID: 27378095
3. Ferencik M, Mayrhofer T, Puchner SB, Lu MT, Maurovich-Horvat P, Liu T, et al. Computed tomogra-
phy-based high-risk coronary plaque score to predict acute coronary syndrome among patients with
acute chest pain—Results from the ROMICAT II trial. J Cardiovasc Comput Tomogr. 2015; 9: 538–545.
https://doi.org/10.1016/j.jcct.2015.07.003 PMID: 26229036
Reproducibility of quantitative coronary computed tomography angiography
PLOS ONE | https://doi.org/10.1371/journal.pone.0207980 December 14, 2018 14 / 16
4. Kristensen TS, Kofoed KF, Ku¨hl JT, Nielsen WB, Nielsen MB, Kelbæk H. Prognostic implications of
nonobstructive coronary plaques in patients with non-ST-segment elevation myocardial infarction: a
multidetector computed tomography study. J Am Coll Cardiol. 2011; 58: 502–509. https://doi.org/10.
1016/j.jacc.2011.01.058 PMID: 21777748
5. Versteylen MO, Kietselaer BL, Dagnelie PC, Joosen IA, Dedic A, Raaijmakers RH, et al. Additive value
of semiautomated quantification of coronary artery disease using cardiac computed tomographic angi-
ography to predict future acute coronary syndrome. J Am Coll Cardiol. 2013; 61: 2296–2305. https://
doi.org/10.1016/j.jacc.2013.02.065 PMID: 23562925
6. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, et al. Multislice computed tomographic
characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007; 50: 319–326.
https://doi.org/10.1016/j.jacc.2007.03.044 PMID: 17659199
7. Dey D, Achenbach S, Schuhbaeck A, Pflederer T, Nakazato R, Slomka PJ, et al. Comparison of quanti-
tative atherosclerotic plaque burden from coronary CT angiography in patients with first acute coronary
syndrome and stable coronary artery disease. J Cardiovasc Comput Tomogr. 2014; 8: 368–374. https://
doi.org/10.1016/j.jcct.2014.07.007 PMID: 25301042
8. Øvrehus KA, Schuhbaeck A, Marwan M, Achenbach S, Nørgaard BL, Bøtker HE, et al. Reproducibility
of semi-automatic coronary plaque quantification in coronary CT angiography with sub-mSv radiation
dose. J Cardiovasc Comput Tomogr. 2015; https://doi.org/10.1016/j.jcct.2015.11.003 PMID: 26712694
9. Papadopoulou S-L, Garcia-Garcia HM, Rossi A, Girasis C, Dharampal AS, Kitslaar PH, et al. Reproduc-
ibility of computed tomography angiography data analysis using semiautomated plaque quantification
software: implications for the design of longitudinal studies. Int J Cardiovasc Imaging. 2013; 29: 1095–
1104. https://doi.org/10.1007/s10554-012-0167-5 PMID: 23224377
10. Rinehart S, Vazquez G, Qian Z, Murrieta L, Christian K, Voros S. Quantitative measurements of coro-
nary arterial stenosis, plaque geometry, and composition are highly reproducible with a standardized
coronary arterial computed tomographic approach in high-quality CT datasets. J Cardiovasc Comput
Tomogr. 2011; 5: 35–43. https://doi.org/10.1016/j.jcct.2010.09.006 PMID: 21131252
11. Laqmani A, Klink T, Quitzke M, Creder DD, Adam G, Lund G. Accuracy of Coronary Plaque Detection
and Assessment of Interobserver Agreement for Plaque Quantification Using Automatic Coronary Pla-
que Analysis Software on Coronary CT Angiography. ROFO Fortschr Geb Rontgenstr Nuklearmed.
2016; 188: 933–939. https://doi.org/10.1055/s-0042-110099 PMID: 27433968
12. C¸olak Y, Afzal S, Nordestgaard BG, Lange P. Characteristics and Prognosis of Never-Smokers and
Smokers with Asthma in the Copenhagen General Population Study. A Prospective Cohort Study. Am J
Respir Crit Care Med. 2015; 192: 172–181. https://doi.org/10.1164/rccm.201502-0302OC PMID:
25914942
13. Linde JJ, Kofoed KF, Sørgaard M, Kelbæk H, Jensen GB, Nielsen WB, et al. Cardiac computed tomog-
raphy guided treatment strategy in patients with recent acute-onset chest pain: results from the rando-
mised, controlled trial: CArdiac cT in the treatment of acute CHest pain (CATCH). Int J Cardiol. 2013;
168: 5257–5262. https://doi.org/10.1016/j.ijcard.2013.08.020 PMID: 23998546
14. Ku¨hl JT, Hove JD, Kristensen TS, Norsk JB, Engstrøm T, Køber L, et al. Coronary CT angiography in
clinical triage of patients at high risk of coronary artery disease. Scand Cardiovasc J SCJ. 2017; 51: 28–
34. https://doi.org/10.1080/14017431.2016.1207799 PMID: 27366972
15. Yang G, Kitslaar P, Frenay M, Broersen A, Boogers MJ, Bax JJ, et al. Automatic centerline extraction of
coronary arteries in coronary computed tomographic angiography. Int J Cardiovasc Imaging. 2012; 28:
921–933. https://doi.org/10.1007/s10554-011-9894-2 PMID: 21637981
16. Boogers MJ, Broersen A, van Velzen JE, de Graaf FR, El-Naggar HM, Kitslaar PH, et al. Automated
quantification of coronary plaque with computed tomography: comparison with intravascular ultrasound
using a dedicated registration algorithm for fusion-based quantification. Eur Heart J. 2012; 33: 1007–
1016. https://doi.org/10.1093/eurheartj/ehr465 PMID: 22285583
17. de Graaf MA, Broersen A, Kitslaar PH, Roos CJ, Dijkstra J, Lelieveldt BPF, et al. Automatic quantifica-
tion and characterization of coronary atherosclerosis with computed tomography coronary angiography:
cross-correlation with intravascular ultrasound virtual histology. Int J Cardiovasc Imaging. 2013; 29:
1177–1190. https://doi.org/10.1007/s10554-013-0194-x PMID: 23417447
18. Broersen A, de Graaf MA, Eggermont J, Wolterbeek R, Kitslaar PH, Dijkstra J, et al. Enhanced charac-
terization of calcified areas in intravascular ultrasound virtual histology images by quantification of the
acoustic shadow: validation against computed tomography coronary angiography. Int J Cardiovasc
Imaging. 2016; 32: 543–552. https://doi.org/10.1007/s10554-015-0820-x PMID: 26667446
19. Dalager MG, Bøttcher M, Andersen G, Thygesen J, Pedersen EM, Dejbjerg L, et al. Impact of luminal
density on plaque classification by CT coronary angiography. Int J Cardiovasc Imaging. 2011; 27: 593–
600. https://doi.org/10.1007/s10554-010-9695-z PMID: 20820922
Reproducibility of quantitative coronary computed tomography angiography
PLOS ONE | https://doi.org/10.1371/journal.pone.0207980 December 14, 2018 15 / 16
20. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989; 45: 255–268.
PMID: 2720055
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical
measurement. Lancet. 1986; 1: 307–310. PMID: 2868172
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;
33: 159–174. PMID: 843571
23. Blackmon KN, Streck J, Thilo C, Bastarrika G, Costello P, Schoepf UJ. Reproducibility of automated
noncalcified coronary artery plaque burden assessment at coronary CT angiography. J Thorac Imaging.
2009; 24: 96–102. https://doi.org/10.1097/RTI.0b013e31819b674b PMID: 19465831
24. de Knegt MC, Linde JJ, Fuchs A, Pham MHC, Jensen AK, Nordestgaard BG, et al. Relationship
between patient presentation and morphology of coronary atherosclerosis by quantitative multidetector
computed tomography. Eur Heart J Cardiovasc Imaging. 2018; https://doi.org/10.1093/ehjci/jey146
PMID: 30325406
25. Kang DK, Im NJ, Park SM, Lim HS. CT comparison of visual and computerised quantification of coro-
nary stenosis according to plaque composition. Eur Radiol. 2011; 21: 712–721. https://doi.org/10.1007/
s00330-010-1970-9 PMID: 20890706
26. Szilveszter B, Celeng C, Maurovich-Horvat P. Plaque assessment by coronary CT. Int J Cardiovasc
Imaging. 2016; 32: 161–172. https://doi.org/10.1007/s10554-015-0741-8 PMID: 26280890
27. Chang H-J, Lin FY, Lee S-E, Andreini D, Bax J, Cademartiri F, et al. Coronary Atherosclerotic Precur-
sors of Acute Coronary Syndromes. J Am Coll Cardiol. 2018; 71: 2511–2522. https://doi.org/10.1016/j.
jacc.2018.02.079 PMID: 29852975
28. Arbab-Zadeh A. Coronary Atheroma Burden Is the Main Determinant of Patient Outcome: But How
Much Detail Is Needed? Circ Cardiovasc Imaging. 2018; 11: e007992. https://doi.org/10.1161/
CIRCIMAGING.118.007992 PMID: 30012827
29. Arbab-Zadeh A, Fuster V. The myth of the “vulnerable plaque”: transitioning from a focus on individual
lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Car-
diol. 2015; 65: 846–855. https://doi.org/10.1016/j.jacc.2014.11.041 PMID: 25601032
Reproducibility of quantitative coronary computed tomography angiography
PLOS ONE | https://doi.org/10.1371/journal.pone.0207980 December 14, 2018 16 / 16
